Progabide
CAS No. 62666-20-0
Progabide( SL 76002 | Halogabide | Gabren | Gabrene )
Catalog No. M26795 CAS No. 62666-20-0
Progabide is an agonist of the gamma-aminobutyric acid receptor.
Progabide is an agonist of the gamma-aminobutyric acid receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | Get Quote |
|
10MG | 72 | Get Quote |
|
25MG | 147 | Get Quote |
|
50MG | 237 | Get Quote |
|
100MG | 372 | Get Quote |
|
200MG | 531 | Get Quote |
|
500MG | 849 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameProgabide
-
NoteResearch use only, not for human use.
-
Brief DescriptionProgabide is an agonist of the gamma-aminobutyric acid receptor.
-
DescriptionProgabide is an agonist of the gamma-aminobutyric acid receptor.(In Vivo):Progabide ( 50, 100 and 200 mg/kg) given IP to male Wistar rats enhance the plasma corticosterone levels by 244, 365, and 476% respectively (t=6.44 to12.55, p<0.01). Progabide (10 mg/kg) fails to change the concentration of corticosterone in plasma (t=0.76, N.S.). The increased plasma corticosterone level induced by administration of 200 mg/kg Progabide is evident 30 (t=2.625, p<0.05), 60 (t=13.13, p<0.001) and 120 min (t=4.07, p<0.01) after drug injection, but returns to the control value 240 min after drug injection (t=0.86, N.S.). Compare with the corresponding control, The greatest corticosterone rise is reached 60 min following the administration of Progabide.
-
In Vitro——
-
In VivoProgabide is a gamma-aminobutyric acid receptor (GABA) agonist. Doses of 50, 100 and 200 mg/kg Progabide given IP to male Wistar rats increase the plasma corticosterone levels by 244, 365 and 476% respectively (t=6.44 to12.55, p<0.01). 10 mg/kg of Progabide fails to change the concentration of corticosterone in plasma (t=0.76, N.S.). The increased plasma corticosterone level induced by administration of 200 mg/kg Progabide is evident 30 (t=2.625, p<0.05), 60 (t=13.13, p<0.001) and 120 min (t=4.07, p<0.01) after drug injection, but returns to the control value 240 min after drug injection (t=0.86, N.S.). The greatest corticosterone rise (compare with the corresponding control) is reached 60 min following the administration of Progabide.
-
SynonymsSL 76002 | Halogabide | Gabren | Gabrene
-
PathwayOthers
-
TargetOther Targets
-
RecptorKv2.2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62666-20-0
-
Formula Weight334.78
-
Molecular FormulaC17H16ClFN2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (746.78 mM)
-
SMILESNC(=O)CCC\N=C(\c1ccc(Cl)cc1)c1cc(F)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Herrington J, et al. Identification of novel and selective Kv2 channel inhibitors. Mol Pharmacol. 2011 Dec;80(6):959-64.
molnova catalog
related products
-
PEN (mouse)
Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide. Activates phospholipase C (PLC)-mediated signaling cascade in mouse hypothalamus.
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
-
Ciwujianoside-B
Ciwujianoside-B is the main component of Acanthopanax, can relieve fatigue, enhance memory, and improve human cognition.